Pfizer antiviral drug could nearly end deaths from COVID-19, company study suggests

A new drug being developed by Pfizer offers the possibility of nearly putting an end to deaths from COVID-19.

When given within five days of the onset of symptoms, the antiviral therapy called Paxlovid, prevented almost 90% of deaths from COVID-19 compared to a placebo, a Pfizer study found.

By the end of the year, the company plans to complete two other studies of the pill, which is given twice a day for five days. Pfizer plans to submit the study data as part of its ongoing rolling submission to the Food and...